Tina Reed

1 week ago | axios.com | Tina Reed |Steph Solis

Illustration: Annelise Capossela/AxiosHundreds of researchers who saw their National Institutes of Health-funded studies halted by the Trump administration could begin working again soon after a federaljudge ordered their funding restored Monday. Why it matters: The ruling was the latest blow to HHS Secretary Robert F.

2 weeks ago | axios.com | Tina Reed

Photo: Kevin Dietsch/Getty ImagesHHS Secretary Robert F. Kennedy on Monday removed all 17 members of the expert panel that makes vaccine policy recommendations to the Centers for Disease Control and Prevention, saying they'd be replaced with "new members currently under consideration." Why it matters: HHS portrayed the unprecedented move as "restoring public trust" in vaccines, but it's expected to introduce anti-vaccine ideology to the influential panel.

2 weeks ago | flipboard.com | Tina Reed

1 hour agoRFK Jr. ousts entire CDC vaccine advisory committeeHealth Secretary Robert F. Kennedy Jr. on Monday removed every member of a scientific committee that advises the Centers for Disease Control and Prevention on how to use vaccines and pledged to replace them with his own picks. Major physicians and public health groups criticized the move to oust all …3 hours ago‘Nobody is coming to D.C.’ for parade: Is Trump about to be embarrassed?

2 weeks ago | axios.com | Tina Reed

Illustration: Lindsey Bailey/AxiosAnimal welfare is becoming part of the Trump health team's agenda, as officials press for changes to drug approvals and product evaluations and portray lab animal testing as a symptom of big-government bloat. Why it matters: The effort is the product of a more than decade-long push to elevate animal welfare issues with the political right that now features congressional oversight hearings and threats to cut off taxpayer funding.

3 weeks ago | axios.com | Tina Reed

Illustration: Brendan Lynch/AxiosManufacturers appeared to stop rapidly stockpiling drugs and medical products from Europe in April, even amid the lingering threat of industry-specific tariffs from the Trump administration, according to federal trade data. Why it matters: An importing surge seen early this spring may have created an inventory bubble, putting pressure on the companies to sell their products before they expire, experts said.